Aliquots of 10 ng of total RNA were used to produce cDNA using the
TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, USA) and
5X RT human TaqMan MicroRNA Assay primers (hsa-miR-195-5p: Assay ID_ 000494; hsa-miR-16: Assay ID_ 000391) according to the manufacturer’s instructions. The reaction was performed in a
Veriti thermal cycler (Applied Biosystems, USA) for 30 min at 16°C, followed by 30 min at 42°C and an additional 5 min at 85°C.
Quantitative reverse transcription PCR (qRT-PCR) was performed using a
7500 Real Time PCR system (Applied Biosystems, USA) and
TaqMan™ Universal PCR Master Mix (Applied Biosystems, USA), 20X primers, and nuclease-free water in a total reaction volume of 10 μL. The cycling process was set up as follows: 50°C for 2 min and incubation at 95°C for 10 min, followed by 45 cycles of 95°C for 15 s and 60°C for 1 min. The threshold standard deviation (SD) for intra-assay and inter-assay replicates was 0.3.
All samples were analyzed in triplicate using the
ABI 7500 platform (Applied Biosystems, USA), and quantification cycle (C
q) values were calculated using
SDS 1.4 software (Applied Biosystems).
de Sales A.C., da Silva I.I., Leite M.C., de Lima Coutinho L., de Albuquerque Cavalcante Reis R.B., Martins D.B., de Lima Filho J.L, & Oliveira Souto F. (2021). miRNA-195 expression in the tumor tissues of female Brazilian breast cancer patients with operable disease. Clinics, 76, e2142.